Local treatments for metastases of renal cell carcinoma: A systematic review

The Lancet Oncology

Volumn 15, Issue 12, 2014, Pages e549-e561

  Dabestani, Saeed ^a   Marconi, Lorenzo ^b   Hofmann, Fabian ^c   Stewart, Fiona ^d   Lam, Thomas B L ^d   Canfield, Steven E ^e   Staehler, Michael ^f   Powles, Thomas ^g   Ljungberg, Börje ^h   Bex, Axel ⁱ  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c SUNDERBY HOSPITAL   (Sweden)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h UMEÅ UNIVERSITY   (Sweden)

ⁱ ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; FLUOROURACIL; INTERLEUKIN 2; SORAFENIB; SUNITINIB; THALIDOMIDE;

ADRENAL METASTASIS; BONE METASTASIS; BRAIN METASTASIS; BRAIN RADIATION; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CYBERKNIFE; CYTOREDUCTIVE SURGERY; HUMAN; IMAGE GUIDED RADIOTHERAPY; KIDNEY CARCINOMA; LIVER METASTASIS; LOCAL THERAPY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; METASTASIS RESECTION; MOLECULARLY TARGETED THERAPY; NEPHRECTOMY; PANCREAS METASTASIS; PARTIAL NEPHRECTOMY; REVIEW; RISK BENEFIT ANALYSIS; SKIN METASTASIS; SPLEEN METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; THYROID METASTASIS; BONE NEOPLASMS; CARCINOMA, RENAL CELL; LUNG NEOPLASMS; PATHOLOGY; SECONDARY;

BONE NEOPLASMS; CARCINOMA, RENAL CELL; HUMANS; LUNG NEOPLASMS; METASTASECTOMY; NEOPLASM METASTASIS;

EID: 84908590983     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70235-9     Document Type: Review

References (74)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005, 173:1853-1862.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
4. Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 2004, 171:1071-1076.
5. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007, 356:115-124.
6. Motzer RJ, Hutson TE, Tomczak P, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009, 27:3584-3590.
7. Heng DY, Rini BI, Garcia J, Wood L, Bukowski RM Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma. Clin Genitourin Cancer 2007, 5:446-451.
8. Heng DY, Xie W, Regan MM, et al. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol 2013, 14:141-148.
9. Naito S, Yamamoto N, Takayama T, et al. Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. Eur Urol 2010, 57:317-325.
10. Bianchi M, Sun M, Jeldres C, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 2012, 23:973-980.
11. Sountoulides P, Metaxa L, Cindolo L Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J Med Case Reports 2011, 5:429.
12. Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 2011, 117:2873-2882.
13. Mehta MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:37-46.
14. Wang XS, Rhines LD, Shiu AS, et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol 2012, 13:395-402.
15. Moher D, Liberati A, Tetzlaff J, Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W64.
16. Higgins JPT, Green S Cochrane handbook for systematic reviews of interventions version 5.0.2. The Cochrane collaboration (accessed Nov 20, 2013). http://www.cochrane-handbook.org/.
17. Dabestani S, Hofmann F, Marconi L, et al. Systematic review methodology for the EAU RCC Guideline update 2013. Arnhem, Netherlands: European Association of Urology (accessed Dec 4, 2013). http://www.uroweb.org/gls/refs/Systematic_methodology_RCC_2013_update.pdf.
18. MacLennan S, Imamura M, Lapitan MC, et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012, 61:972-993. the UCAN Systematic Review Reference Group, the EAU Renal Cancer Guideline Panelthe EAU Renal Cancer Guideline Panel.
19. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926. the GRADE Working Group.
20. Parmar MK, Torri V, Stewart L Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17:2815-2834.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
22. Rodgers M, Arai L, Britten N, et al. Guidance on the conduct of narrative synthesis in systematic reviews: a comparison of guidance-led narrative synthesis versus meta-analysis. 14th Cochrane Colloquium Dublin, Ireland Oct 23-26, 2006 2006, Centre for Reviews and Dissemination, University of York, (accessed Dec 4, 2013). http://www.york.ac.uk/inst/crd/Posters/Guidance%20on%20the%20conduct%20of%20narrative%20synthesis%20in%20systematic%20review.pdf.
23. Amiraliev A, Pikin O, Alekseev B, Kalpinksiy A Treatment strategy in patients with pulmonary metastases of renal cell cancer. Interact Cardiovasc Thorac Surg 2012, 15(suppl):S20.
24. Petralia G, Roscigno M, Zigeuner R, et al. Complete metastasectomy is an independent predictor of cancer-specific survival in patients with clinically metastatic renal cell carcinoma. Eur Urol Suppl 2010, 9:162.
25. Staehler MD, Kruse J, Haseke N, et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 2010, 28:543-547.
26. Staehler M, Kruse J, Haseke N, et al. Metastasectomy significantly prolongs survival in patients with metastatic renal cancer. Eur Urol Suppl 2009, 8:181.
27. Eggener SE, Yossepowitch O, Kundu S, Motzer RJ, Russo P Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma. J Urol 2008, 180:873-878.
28. Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, Di Carlo V Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?. Ann Surg Oncol 2008, 15:1161-1168.
29. Brinkmann OA, Semik M, Gosherger G, Hertle L The role of residual tumor resection in patients with metastatic renal cell carcinoma and partial remission following immunochemotherapy. Eur Urol 2007, 6(suppl):641-645.
30. Kwak C, Park YH, Jeong CW, Lee SE, Ku JH Metastasectomy without systemic therapy in metastatic renal cell carcinoma: comparison with conservative treatment. Urol Int 2007, 79:145-151.
31. Russo P, Synder M, Vickers A, Kondagunta V, Motzer R Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer. Scientific World J 2007, 7:768-778.
32. Lee SE, Kwak C, Byun SS, et al. Metastatectomy prior to immunochemotherapy for metastatic renal cell carcinoma. Urol Int 2006, 76:256-263.
33. Zelefsky MJ, Greco C, Motzer R, et al. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2012, 82:1744-1748.
34. Hunter GK, Balagamwala EH, Koyfman SA, et al. The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma. Pract Radiat Oncol 2012, 2:e95-100.
35. Fuchs B, Trousdale RT, Rock MG Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment. Clin Orthop Relat Res 2005, 431:187-192.
36. Fokas E, Henzel M, Hamm K, Surber G, Kleinert G, Engenhart-Cabillic R Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: Analysis of 88 patients. Strahlenther Onkol 2010, 186:210-217.
37. Ikushima H, Tokuuye K, Sumi M, et al. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2000, 48:1389-1393.
38. Albiges L, Oudard S, Negrier S, et al. Complete remission with tyrosine kinase inhibitors in renal cell carcinoma. J Clin Oncol 2012, 30:482-487.
39. Kierney PC, van Heerden JA, Segura JW, Weaver AL Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol 1994, 1:345-352.
40. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS Resection of metastatic renal cell carcinoma. J Clin Oncol 1998, 16:2261-2266.
41. Oddsson SJ, Hardarson S, Petursdottir V, et al. Synchronous pulmonary metastases from renal cell carcinoma-a whole nation study on prevalence and potential resectability. Scand J Surg 2012, 101:160-165.
42. Leibovich BC, Cheville JC, Lohse CM, et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 2005, 174:1759-1763. discussion 1763.
43. Steiner T, Kirchner H, Siebels M, et al. The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma. J Cancer Res Clin Oncol 2010, 136:905-910.
44. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999, 17:2530-2540.
45. Heng DY, Xie W, Regan MM, et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol 2009, 27:5794-5799.
46. Patil S, Figlin RA, Hutson TE, et al. Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol 2011, 22:295-300.
47. Assouad J, Petkova B, Berna P, Dujon A, Foucault C, Riquet M Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors. Ann Thorac Surg 2007, 84:1114-1120.
48. Kanzaki R, Higashiyama M, Fujiwara A, et al. Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience. Eur J Cardiothorac Surg 2011, 39:167-172.
49. Marulli G, Sartori F, Bassi PF, dal Moro F, Gino Favaretto A, Rea F Long-term results of surgical management of pulmonary metastases from renal cell carcinoma. Thorac Cardiovasc Surg 2006, 54:544-547.
50. Mineo TC, Ambrogi V, Tonini G, Nofroni I Pulmonary metastasectomy: might the type of resection affect survival?. J Surg Oncol 2001, 76:47-52.
51. Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 2002, 74:1653-1657.
52. Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 2002, 73:1082-1087.
53. Winter H, Meimarakis G, Angele MK, et al. Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma. J Urol 2010, 184:1888-1894.
54. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 2005, 48:77-81. discussion 81-82.
55. Murthy SC, Kim K, Rice TW, et al. Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?. Ann Thorac Surg 2005, 79:996-1003.
56. Meimarakis G, Angele M, Staehler M, et al. Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases. Am J Surg 2011, 202:158-167.
57. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366:643-648.
58. Nguyen QN, Shiu AS, Rhines LD, et al. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76:1185-1192.
59. Lin PP, Mirza AN, Lewis VO, et al. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am 2007, 89:1794-1801.
60. Baloch KG, Grimer RJ, Carter SR, Tillman RM Radical surgery for the solitary bony metastasis from renal-cell carcinoma. J Bone Joint Surg Br 2000, 82:62-67.
61. Jung ST, Ghert MA, Harrelson JM, Scully SP Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res 2003, 409:223-231.
62. Kollender Y, Bickels J, Price WM, et al. Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol 2000, 164:1505-1508.
63. Muacevic A, Kreth FW, Mack A, Tonn JC, Wowra B Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma. Minim Invasive Neurosurg 2004, 47:203-208.
64. Shuch B, La Rochelle JC, Klatte T, et al. Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 2008, 113:1641-1648.
65. Gaspar LE, Scott C, Murray K, Curran W Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:1001-1006.
66. Cannady SB, Cavanaugh KA, Lee SY, et al. Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Radiat Oncol Biol Phys 2004, 58:253-258.
67. Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77:655-661.
68. Marko NF, Angelov L, Toms SA, et al. Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases. World Neurosurg 2010, 73:186-193.
69. Hatzaras I, Gleisner AL, Pulitano C, et al. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford) 2012, 14:532-538.
70. Goering JD, Mahvi DM, Niederhuber JE, Chicks D, Rikkers LF Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg 2002, 183:384-389.
71. Svedman C, Sandström P, Pisa P, et al. A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 2006, 45:870-875.
72. Stinauer MA, Kavanagh BD, Schefter TE, et al. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol 2011, 6:34.
73. Tanis PJ, van der Gaag NA, Busch OR, van Gulik TM, Gouma DJ Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br J Surg 2009, 96:579-592.
74. Phillips CK, Taneja SS The role of lymphadenectomy in the surgical management of renal cell carcinoma. Urol Oncol 2004, 22:214-223.